This year the American College of Rheumatology (ACR) annual scientific congress took place in the city of San Diego, CA. Those who have regularly attended the ACR meetings will undoubtedly have remembered previous editions in this beautiful city. Each time one visits San Diego it is striking how much it develops, and just as striking […]
The 2016 ACR congress
The ACR congress also featured, as it always does, a lot of exciting activities and new findings on SLE. Lupus gives up its secrets only very slowly, but there were many presentations from researchers working on elucidating the etiology and pathophysiology of this disease. I was most impressed by results from different groups that point […]
Lupus Awareness Month and Lupus Science & Medicine
Lupus, SLE, or “systemic lupus erythematosus” is a disease that affects millions of people worldwide, a disease that strikes mostly women in all age groups including adolescents and young adults, a disease that can cause chronic or recurring symptoms from many different parts of the body, a disease that can be treated to some extent, […]
Professor Jane Salmon about the PROMISSE study
Dr. Jane Salmon is a Professor of Medicine and Professor of Obstetrics and Gynecology at Weill Cornell Medical College and the Collette Kean Research Professor at Hospital for Special Surgery in New York, USA. She is the principle investigator in the PROMISSE study, which has generated very important data and received great attention. – Professor […]
Post ACR 2015: Professor Richard Furie about anifrolumab
Professor Richard Furie is the chief of the Division of Rheumatology of the North Shore-Long Island Jewish Health System in New York. His research in the field of SLE is profound. At the 2015 ACR Annual Meeting in San Francisco, professor Furie presented results from a phase II trial of anifrolumab, a type I IFN […]
Professor Ronald van Vollenhoven about Lupus Science & Medicine
Professor Ronald van Vollenhoven is the Head of the Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID) at Karolinska Institutet in Stockholm, Sweden, and one of the Editors-in-chief for Lupus Science & Medicine. – Professor van Vollenhoven, we have heard you many times encouraging the rheumatologists to treat to target, both […]
Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE
Dialogue by Julia F Simard and Jinoos Yazdany. Originally published here. Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE).1 Despite extensive and ongoing research in this area, few risk factors, including traditional ones such as smoking and hypertension, explain a significant proportion of the risk. There is a robust scientific […]
Professor Bernard Lauwerys
This is the first in our series of author profiles. Please let me introduce you to Professor Bernard Lauwerys who published the paper “sIL7R concentrations in the serum reflect disease activity in the lupus kidney” which can be found here. Hi Professor Lauwerys please can you tell us a bit about yourself and how you […]